2009-12-21 07:30 Eisai Obtains Worldwide Rights to Develop, Market and Manufacture AKR-501, Therapeutic Agent for Thrombocytopenia
Tag: pariet
Pressmeddelanden
2009-12-21 07:00 Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Hauro Naito) today announced the completion of construction of the Eisai Knowledge Centre, India, the Company’s new manufacturing and process research base in India.
Bilder
Dokument
2009-04-14 12:58 Japans 4th largest pharmaceutical company - establishment in the Nordic region...
